Leo Ehrlich
Vermögen: 4 334 $ am 28.02.2026
Vermögen: 4 334 $ am 28.02.2026
Mr. Leo Ehrlich, CPA, is a Chairman, CEO, Chief Financial Officer & Secretary at Innovation Pharmaceuticals, Inc. Mr. Ehrlich was previously employed as a Chief Financial Officer by Cellceutix Pharma, Inc., a Chief Financial Officer by NanoViricides, Inc. /Old/, a President, CEO, COO, CFO, Secretary & Director by StatSure Diagnostic Systems, Inc., and a Chief Financial Officer & Director by NanoViricides, Inc. He received his undergraduate degree from Baruch College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.09.2023 | 4’333’936 ( -.--% ) | 4 334 $ | 28.02.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| INNOVATION PHARMACEUTICALS INC. | Vorstandsvorsitzender | 05.11.2010 |
| Unternehmen | Position | Ende |
|---|---|---|
Cellceutix Pharma, Inc.
Cellceutix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as an early stage developmental biopharmaceutical company | Finanzdirektor/CFO | 06.12.2007 |
| NANOVIRICIDES, INC. | Finanzdirektor/CFO | 16.05.2007 |
NanoViricides, Inc. /Old/
NanoViricides, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Finanzdirektor/CFO | 01.05.2007 |
| STATSURE DIAGNOSTIC SYSTEMS, INC. | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
StatSure Diagnostic Systems, Inc.
StatSure Diagnostic Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical specimen collection devices for the rapid tests of infectious diseases | Health Technology |
Baruch College
Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoViricides, Inc. /Old/
NanoViricides, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
NanoViricides, Inc.
NanoViricides, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes anti-viral therapeutics | Health Technology |
Cellceutix Pharma, Inc.
Cellceutix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as an early stage developmental biopharmaceutical company | Health Technology |
Innovation Pharmaceuticals, Inc.
Innovation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company, which focuses on discovering small molecule drugs for hard to treat diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen